Director of Global Market Access for Oncology managing access strategy and payer tools. Collaborating with global teams to optimize patient access for Early Bladder indications.
Responsibilities
Lead the cross functional Global access, Team.
Actively collaborate with the global functions including Oncology Global Market Access and Pricing Team, Oncology Global Marketing team, Global Pricing, Value and Implementation Team, Policy, and the US & ex-US Regional Oncology Payer Strategy teams, to provide critical market access viewpoints across stakeholder work streams.
Engage with key stakeholders to ensure market access considerations in the target product profile and deliver a reimbursable payer value proposition.
Plan for various landscape and pricing research to support pricing of new products in US and ex-US key countries.
Manage analysis and price forecasting of Oncology Brands and Business Development Opportunities.
Work closely with the cross-functional teams to develop payer value proposition and scientific narratives.
Develop and launch efficient payer value tool for launch products.
Serve as active standing member for Value and Implementation teams and ad-hoc member for Pharmaceutical Development/ Early Development teams.
Monitor Oncology global competitors and comparator prices and implement innovative global access/pricing strategies for new products.
Requirements
Bachelor's degree
Master's degree (MBA/MS) or other post-graduate Degree required.
At least 5 years of experience in marketing, market research, pricing/ reimbursement, outcomes research or managed markets or business development.
Knowledgeable about product development and commercialization process.
Relevant functional area experience in product launch.
Understanding of the global payer environment and perspectives.
Proven success working within large and complex strategic initiatives.
Experience successfully leading cross functional matrix teams.
Strong financial and analytical skills.
Strong project management and implementation/operational skills.
Strong verbal and written communications skills.
Strong commercial orientation and business acumen.
Strategic thinking and integration skills.
Benefits
medical, dental, vision healthcare and other insurance benefits (for employee and family)
Technical Director, Structures overseeing bridge and structural engineering deliverables for MTO transportation projects. Leading multi - disciplinary teams and ensuring compliance with MTO standards.
Lead qualitative research strategy aligned with business goals at Ipsos. Design and oversee qualitative studies, ensuring quality and innovation in methodologies.
IT Infrastructure Engineer managing Active Directory systems at EOLEN. Ensuring security and development of directory infrastructures in high - demand technical environments.
Executive Director driving the TA strategy for Oncology & Hematology at Novartis. Leading collaboration teams to support commercial insights, pipeline development, and strategic alignment.
Non - Executive Director providing strategic oversight and governance for Health Innovation KSS. Engaging with healthcare innovation and investment opportunities to enhance regional growth.
Product Director managing strategic initiatives for a $2.2B Workers Compensation line at an insurance company. Leading cross - functional teams and driving product strategies.
Director I, Pre - Access responsible for leading the team across multiple markets in healthcare revenue cycle management. Focused on performance excellence and regulatory compliance at Ensemble Health Partners.
Director of Healthcare engaging with industry partners to enhance CommBank Health’s market presence. Leading initiatives for client acquisition and business development in the healthcare vertical.
Finance Director managing financial planning and analysis for Treasury Management and Merchant Services. Partnering with leadership for strategic decision - making and performance tracking.
Associate Director managing the Discovery IT project portfolio at Eisai. Drive strategic initiatives ensuring alignment with R&D objectives in a pharmaceutical environment.